Detalhe da pesquisa
1.
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics.
Ann Rheum Dis
; 81(1): 143-145, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34556483